| MEsenchymal StEm Cells for Multiple Sclerosis (NCT02403947) | University Hospital, Toulouse | 2015-02-01 |
| Stress Urinary Incontinence in Women With Multiple Sclerosis (NCT03332654) | Lille Catholic University | 2015-02-01 |
| D-mannose for the Prevention of UTIs in Multiple Sclerosis (NCT02490046) | University College, London | 2015-02-01 |
| Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise Therapy (NCT02466165) | Bert Op't Eijnde | 2015-02-01 |
| Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients (NCT03092544) | Multiple Sclerosis Center of Northeastern New York | 2015-02-01 |
| Rouxbe Pilot for MS (NCT02424825) | Oregon Health and Science University | 2015-02-01 |
| Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study (NCT02408367) | Jens Bansi | 2015-02-01 |
| Impact of Multiple Sclerosis From the Viewpoint of the Patients and Their Caregivers (NCT02388334) | Rennes University Hospital | 2015-01-15 |
| Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics (NCT02369224) | Brown, Theodore R., M.D., MPH | 2015-01-01 |
| WEB-Based Physiotherapy for People With Multiple Sclerosis (NCT02508961) | University of Glasgow | 2015-01-01 |
| Preventing Falls and Participation Restrictions in Neurological Diseases (NCT03570268) | Fondazione Don Carlo Gnocchi ETS | 2015-01-01 |
| Internet-based MOTOmed Exercise to Reduce Spasticity and Improve Physical Function in Persons With Multiple Sclerosis (NCT03548974) | University of Erlangen-Nürnberg | 2015-01-01 |
| Effects of Core Stability Training on Gait in Multiple Sclerosis Patients (NCT03442049) | Hacettepe University | 2015-01-01 |
| Phototherapy in Persons With Multiple Sclerosis (NCT02365259) | University of Illinois at Urbana-Champaign | 2015-01-01 |
| A RCT of Telephone-supported ACT in MS (NCT02596633) | University of Nottingham | 2015-01-01 |
| Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) (NCT02294058) | Celgene | 2014-12-03 |
| Transcranial Doppler in Multiple Sclerosis (NCT02389426) | Universitair Ziekenhuis Brussel | 2014-12-01 |
| Lakeshore Examination of Activity and Disability Exercise Response Study (NCT02533882) | University of Alabama at Birmingham | 2014-12-01 |
| Safety and Tolerability of Quetiapine in Multiple Sclerosis (NCT02087631) | University of Calgary | 2014-12-01 |
| Efficacy of PoNS in Reducing Symptoms of Multiple Sclerosis (NCT04496531) | Helius Medical Inc | 2014-12-01 |
| Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension (NCT02383550) | Clinique Neuro-Outaouais | 2014-12-01 |
| Fall Risk Reduction in Multiple Sclerosis (FIRMS) (NCT02314585) | University of Illinois at Urbana-Champaign | 2014-12-01 |
| An Online Self-Guided Meditation Course for Individuals With Multiple Sclerosis (NCT02391298) | Haley Duncanson | 2014-12-01 |
| Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS (NCT02259361) | Sheba Medical Center | 2014-11-01 |
| Robot-assisted Arm Training in Multiple Sclerosis (NCT03561155) | Universita di Verona | 2014-11-01 |
| Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis (NCT02326935) | American CryoStem Corporation | 2014-11-01 |
| Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes (NCT02297932) | Kessler Foundation | 2014-11-01 |
| Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study (NCT04306939) | University of Pittsburgh | 2014-11-01 |
| Exercise Intensity and Immune Function in Multiple Sclerosis (NCT02264704) | University of the West of Scotland | 2014-11-01 |
| Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients (NCT02142764) | University Hospital, Bordeaux | 2014-11-01 |
| IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis (NCT02486562) | Accelerated Cure Project for Multiple Sclerosis | 2014-11-01 |
| Vitamin D3 and the Stress-axis in MS (NCT02096133) | Academic MS Center Limburg | 2014-10-13 |
| Psychometric Properties Mobility Measures MS (NCT02339688) | Hasselt University | 2014-10-01 |
| Influence of Exercise on the Mobility and Balance of Individuals With Multiple Sclerosis (NCT02524483) | University of Nebraska | 2014-10-01 |
| Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk (NCT02440126) | Rocky Mountain MS Research Group, LLC | 2014-10-01 |
| Protective Role of Oxcarbazepine in Multiple Sclerosis (NCT02104661) | Queen Mary University of London | 2014-10-01 |
| Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS (NCT02212886) | Mapi Pharma Ltd. | 2014-10-01 |
| Psychometric Properties Upper Limb Function Measures Multiple Sclerosis (NCT02339675) | Hasselt University | 2014-10-01 |
| Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis (NCT02280096) | Coordinación de Investigación en Salud, Mexico | 2014-10-01 |
| Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers (NCT02269930) | Biogen | 2014-10-01 |
| Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis (NCT02274935) | University of Illinois at Urbana-Champaign | 2014-10-01 |
| Effect of Motor Cortex Versus Sacral Magnetic Stimulation in Multiple Sclerosis Patients With Urinary Tract Dysfunction (NCT03434873) | Cairo University | 2014-10-01 |
| Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks (NCT02232061) | Novartis Pharmaceuticals | 2014-09-29 |
| The Italian Multiple Sclerosis and Related Disorders Register (NCT07636876) | Fondazione Italiana Sclerosi Multipla | 2014-09-17 |
| Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720) (NCT02408380) | McGill University | 2014-09-01 |
| Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects (NCT02287948) | University Hospital of Ferrara | 2014-09-01 |
| Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis (NCT02219932) | Biogen | 2014-09-01 |
| A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS) (NCT02045732) | Pfizer | 2014-09-01 |
| Exercise & Brain Health in MS (NCT02263339) | Oregon Health and Science University | 2014-09-01 |
| Fingolimod Real World Experience: the French Grand-Est Cohort (NCT02799199) | CHU de Reims | 2014-09-01 |
| Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (NCT02836327) | Chinese PLA General Hospital | 2014-09-01 |
| Efficacy Study of "Imaginative Distention", a Self Managed Tool to Cope With Fatigue,Insomnia and Stress in pw Insomnia and pw MS (NCT02290990) | Niguarda Hospital | 2014-09-01 |
| Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures (NCT02777060) | University of Arizona | 2014-09-01 |
| Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate (NCT02307877) | University of Colorado, Denver | 2014-09-01 |
| tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis (NCT02538094) | Johns Hopkins University | 2014-09-01 |
| Step it Up: An Exercise and Behaviour Change Programme for People With Multiple Sclerosis (NCT02301442) | University of Limerick | 2014-09-01 |
| The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis (NCT02282878) | Yale University | 2014-09-01 |
| Association Between Fatigue and Balance in Patients With Multiple Sclerosis (NCT04215354) | Imam Abdulrahman Bin Faisal University | 2014-09-01 |
| Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS) (NCT03541226) | University Hospital, Lille | 2014-09-01 |
| A Telemedicine Mindfulness-based Intervention for People With Multiple Sclerosis and Their Caregivers (NCT02364505) | Fondazione Don Carlo Gnocchi ETS | 2014-09-01 |
| Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis (NCT03632473) | University Hospital, Basel, Switzerland | 2014-08-28 |
| Obstetric Anesthesia and Analgesia and Multiple Sclerosis (NCT03247894) | Brno University Hospital | 2014-08-01 |
| Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS (NCT02218879) | Yale University | 2014-08-01 |
| Balance and Falls in Multiple Sclerosis (NCT02209467) | Örebro County Council | 2014-08-01 |
| A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada (NCT02367222) | University of Manitoba | 2014-08-01 |
| Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course (NCT02301572) | Weill Medical College of Cornell University | 2014-08-01 |
| Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients (NCT02184494) | Florida State University | 2014-08-01 |
| Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis (NCT02201108) | Genzyme, a Sanofi Company | 2014-07-16 |
| Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis (NCT02308670) | University at Buffalo | 2014-07-01 |
| A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults (NCT02201849) | Biogen | 2014-07-01 |
| Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)? (NCT02588053) | University of Colorado, Denver | 2014-07-01 |
| Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients (NCT02789670) | University Hospital, Lille | 2014-07-01 |
| Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study (NCT02137044) | University of Washington | 2014-07-01 |
| BAY86-5046 (Betaseron), Non Interventional Studies (NCT02121444) | Bayer | 2014-06-23 |
| Mindfulness-based Stress Reduction in Multiple Sclerosis (NCT02136485) | NHS Greater Glasgow and Clyde | 2014-06-02 |
| Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation (NCT02123537) | University of Manitoba | 2014-06-01 |
| Safety and Efficacy of BMMNC in Multiple Sclerosis (MS) (NCT01883661) | Chaitanya Hospital, Pune | 2014-06-01 |
| Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis (NCT02133664) | Oregon Health and Science University | 2014-06-01 |
| Robot-assisted Gait Training in Patients With Multiple Sclerosis: Efficacy and Comparison With Traditional Methods (NCT02291107) | Habilita, Ospedale di Sarnico | 2014-06-01 |
| Abdominal Massage for Bowel Dysfunction (NCT03166007) | Glasgow Caledonian University | 2014-06-01 |
| RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate (NCT02117050) | EMD Serono | 2014-06-01 |
| Enhance Wellness for Individuals With Long-Term Physical Disabilities (NCT02815878) | University of Washington | 2014-05-12 |
| Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis (NCT02086188) | Theodore R. Brown, MD MPH | 2014-05-01 |
| Outcomes Data of Adipose Stem Cells to Treat Multiple Sclerosis (NCT02157064) | StemGenex | 2014-05-01 |
| Resistance Training and Amino Pyridine in Multiple Sclerosis (NCT02143167) | University of Southern Denmark | 2014-05-01 |
| Efficacy of MBI for Depressive Symptoms in Patients With MS (NCT02611401) | University of Turin, Italy | 2014-05-01 |
| Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging (NCT02767609) | Loma Linda University | 2014-05-01 |
| A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers (NCT02046629) | Sanofi | 2014-05-01 |
| Implementing Physical Activity Guidelines for Adults With MS (NCT02100020) | McMaster University | 2014-05-01 |
| Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis (NCT02152085) | University of Colorado, Boulder | 2014-05-01 |
| High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases (NCT01973517) | Stanford University | 2014-04-01 |
| Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis (NCT01933802) | Tisch Multiple Sclerosis Research Center of New York | 2014-04-01 |
| Allocentric Memory in MS and Resting State Functional MRI (NCT02118298) | Yale University | 2014-04-01 |
| Trekking Poles to Aid Multiple Sclerosis Gait Impairment (NCT02227524) | Rowan University | 2014-04-01 |
| Speed of Processing Training to Improve Cognition in Multiple Sclerosis (NCT02301260) | Kessler Foundation | 2014-04-01 |
| Progressive Muscle Relaxation Effect on Sleep Quality, Depression and Stress in People With Multiple Sclerosis (NCT02673827) | Federal University of Espirito Santo | 2014-04-01 |
| Neuroretinal Biomarkers in Neurodegenerative Diseases (NCT02047760) | University of Edinburgh | 2014-03-01 |
| Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients (NCT02099370) | University of South Florida | 2014-03-01 |
| Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri (NCT02137109) | Biogen | 2014-03-01 |
| French Adaptation of the California Card Sorting Task (CCST) in Multiple Sclerosis (NCT02887352) | Fondation Ophtalmologique Adolphe de Rothschild | 2014-03-01 |